Free Trial
NASDAQ:HROW

Harrow Q2 2025 Earnings Report

Harrow logo
$31.23 -0.53 (-1.67%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$31.85 +0.62 (+1.99%)
As of 08/1/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Harrow EPS Results

Actual EPS
N/A
Consensus EPS
$0.01
Beat/Miss
N/A
One Year Ago EPS
N/A

Harrow Revenue Results

Actual Revenue
N/A
Expected Revenue
$64.23 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Harrow Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Tuesday, August 12, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Harrow Earnings Headlines

This Crypto Is Set to Explode in January
Free summit reveals where Bitcoin goes after $120k Don't miss this rare opportunity to learn directly from the experts who are driving this market…
See More Harrow Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Harrow? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Harrow and other key companies, straight to your email.

About Harrow

Harrow (NASDAQ:HROW) operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in Nashville, Tennessee.

View Harrow Profile

More Earnings Resources from MarketBeat